Reference – Multiple Sclerosis
- Coyle PK. Disease-modifying agents in multiple sclerosis. Ann Indian Acad Neurol. 2009 Oct–Dec; 12(4): 273–282.
- Gasperini C, Ruggieri S, Pozzilli C. Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets. Therapeutics and Clinical Risk Management 2010; (6): 391–399
- Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR, on behalf of the Fampridine MS-F203 Investigators. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. The Lancet 2009; 373 (9665): 732-8.
- Calabresi PA. Diagnosis and Management of Multiple Sclerosis. Am Fam Physician. 2004 Nov 15;70(10):1935-1944.
- Harrison’s Principles of Internal Medicine 17th Edition.
Editor: Dr. Sunil Shroff
Technically Checked by: Lingaraj